Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor + Thalidomide + Dexamethasone in RRMM
NCT04891744Phase 2Unknown
- Start
- Jul 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in multiple myeloma (MM). Status: unknown.
02
Drugs
selinexor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04891744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04891744.